Skip to main content
GLP-1 Agonists

Considering GLP-1 Injections for Weight Loss? Here Are 8 Things to Know Before You Start

Alyssa Billingsley, PharmDChristina Aungst, PharmD, MWC
Written by Alyssa Billingsley, PharmD | Reviewed by Christina Aungst, PharmD, MWC
Updated on August 13, 2026

Key takeaways:

  • Glucagon-like peptide-1 (GLP-1) injections help reduce appetite and slow digestion, leading to weight loss for many people. Options include Wegovy and Wegovy HD (semaglutide), Zepbound (tirzepatide), and Saxenda (liraglutide).

  • Weight loss with GLP-1 injections can be significant, but results and side effects vary from person to person.

  • GLP-1 injections are intended for long-term use and work best alongside lifestyle changes.

  • If you’re new to using GoodRx for Wegovy savings, you can pay an introductory price of $199 per month for the first two fills of injections (with certain doses). Access Zepbound KwikPen through GoodRx starting at $299 per month. Subscribers to GoodRx for Weight Loss can also access FDA-approved, brand-name GLP-1 medications.

Save on related medications

Glucagon-like peptide-1 (GLP-1) injections such as Wegovy and Wegovy HD (semaglutide), Zepbound (tirzepatide), and Saxenda (liraglutide) can help many people lose a meaningful amount of weight. But they aren’t a quick fix, and they aren’t right for everyone.

Before starting GLP-1 injections, it’s good to understand how they work, the possible benefits, and what trade-offs come with treatment — such as side effects and cost. If you’re considering a GLP-1 injection for weight loss, here are eight key things to know before you begin.

1. GLP-1 injections work by changing appetite and digestion

Featuring Christina Aungst, PharmD, MWC, Alyssa Billingsley, PharmDReviewed by Stacia Woodcock, PharmD | August 5, 2026

GLP-1 injections — or GLP-1 receptor agonists — mimic the natural hormone GLP-1, which helps regulate appetite, fullness, and digestion. Some also mimic a second hormone, glucose-dependent insulinotropic polypeptide (GIP), for additive effects. These are called dual GIP / GLP-1 receptor agonists.

GLP-1 injections work by:

  • Reducing appetite so you feel less hungry

  • Helping you feel full sooner during meals

  • Slowing digestion, which keeps you feeling satisfied longer

  • Reducing food cravings and “food noise," making it easier to stop thinking about food between meals

Together, these effects can make it easier to eat less without constantly feeling hungry. And this helps support weight loss.

2. Not all GLP-1 injections are the same

GLP-1 injections work in similar ways for weight loss, but they’re not identical. They differ in their active ingredients and dosage schedules, as well as how much weight people typically lose. They also have different dosage form options, including single-use and multidose pens, and single-use vials.

Wegovy, Wegovy HD, and Zepbound are all injected once weekly and tend to lead to more weight loss on average. Saxenda, on the other hand, is injected once daily and generally results in more modest weight loss. Wegovy and Saxenda are approved for people ages 12 and older, while Zepbound and Wegovy HD are approved only for adults.

In addition to helping people lose weight, Wegovy is also prescribed for its cardiovascular and liver-related benefits. This can make it a good option if you have heart disease or metabolic dysfunction-associated steatohepatitis (a type of fatty liver disease), or MASH. Alternatively, Zepbound can be a good choice if you have moderate-to-severe obstructive sleep apnea, since it’s approved for this condition.

Here’s how GLP-1 injections compare:


Saxenda

Wegovy

Zepbound

Dose frequency

Daily

Weekly

Weekly

Dosage forms

Multidose pen

Single-use pen

Single-use pen, multidose pen (KwikPen), and single-use vial

Approved uses

Weight loss in certain people ages 12 and older

Weight loss in certain people ages 12 and older (adults only for Wegovy HD)

Cardiovascular risk reduction in certain adults with heart disease

MASH in adults

Weight loss in certain adults

Average weight loss (%)

About 8% at 56 weeks 

(almost 13 months)

About 15% (Wegovy)

or 19% (Wegovy HD) at 72 weeks (16.5 months)

About 21% at 72 

weeks

A healthcare professional can help determine which option is the best fit based on your health history, preferences, and budget.

Good to know: You may also see compounded GLP-1 injections, such as custom microdoses, being advertised. These products are made by pharmacies and are not FDA approved. They also aren't exactly the same as Wegovy, Zepbound, or Saxenda.

3. Weight loss can be significant, but results vary

Many people lose a meaningful amount of weight with GLP-1 injections. During clinical trials, participants have lost an average of about 10% to 20% or more of their starting body weight, depending on the medication and dose.

That said, results vary from person to person. In addition to the medication and dose, factors such as treatment duration, lifestyle habits, and individual biology all play a role. Some people lose weight steadily, while others see slower or more modest changes. There are also those who don't respond at all.

Weight loss with GLP-1 injections tends to happen gradually over several months. Setting realistic expectations and focusing on long-term progress can help make treatment more sustainable.

4. Side effects are common, especially early on

Side effects are fairly common with GLP-1 injections, particularly when you start treatment or if you increase your dose. Most GLP-1 side effects are gastrointestinal (GI) and may include:

These side effects are usually temporary and often improve as the body adjusts to the medication. But while GLP-1 side effects are mild and manageable for some people, they can be more severe for others. That’s why it’s best to keep in touch with your care team, so they can make adjustments if needed.

Starting with a low dose that’s increased gradually helps reduce both how severe side effects feel and how long they last. Lifestyle factors, such as your diet, fluid intake, and physical activity, can also influence how well you tolerate treatment.

While less common, serious side effects have also been linked to GLP-1s, including:

GLP-1s also carry a boxed warning (the FDA’s strongest medication warning) for an increased risk of thyroid C-cell tumors. This is based on findings from animal studies and hasn’t been confirmed in humans.

5. GLP-1 injections are meant for long-term use

GLP-1 injections are generally intended for long-term treatment, not short-term weight loss. These medications work best when they’re used consistently over time.

Many people who stop using GLP-1 injections regain some or all of the weight they lost. Because of this, ongoing treatment may be needed to maintain results, though treatment plans can change. In some cases, your prescriber may recommend slowly tapering your dose or switching to a GLP-1 pill over time.

Before you start treatment, a healthcare professional can help you determine how long you may need to use GLP-1 injections. If you’re already using a GLP-1, your prescriber can advise whether adjustments are needed based on your progress, goals, and side effects.

6. GLP-1 injections aren't a good fit for everyone

GLP-1 injections can be effective for weight loss, but they aren’t appropriate for everyone. You may be told to avoid GLP-1 injections if you:

  • Have a personal or family history of medullary thyroid cancer

  • Have multiple endocrine neoplasia syndrome type 2

  • Have a history of pancreatitis

  • Have severe gastrointestinal issues, such as gastroparesis

  • Are pregnant or breastfeeding

  • Are allergic to any ingredient in the GLP-1 injection

A healthcare professional can review your medical history, current medications, and weight-loss goals to help determine whether a GLP-1 injection is safe and appropriate for you.

Quiz: Think you know how to use a GLP-1?

7. Lifestyle changes still matter

GLP-1 injections can support weight loss, but they work best when combined with healthy lifestyle habits. These medications aren’t a substitute for good nutrition, exercise, and other behaviors that support long-term health.

Focusing on balanced, protein-rich meals, staying hydrated, and being physically active can help improve results from GLP-1s and reduce side effects. Getting enough sleep and managing stress also play important roles in weight management.

Building positive, sustainable habits alongside using GLP-1 injections can help you maintain weight loss over time and support overall health.

8. There are ways to make GLP-1 injections more affordable

For some people, cost can be a barrier to starting or continuing GLP-1 injections. But there are several ways to help make these medications more affordable:

  • Save with GoodRx. If you’re new to using GoodRx for Wegovy savings, you can pay an introductory price of $199 per month for the first two fills of injections (with certain doses). For future fills and other Wegovy doses, you can pay $349 (standard Wegovy) or $399 (Wegovy HD) per month. Access Zepbound KwikPen through GoodRx starting at $299 per month. Subscribers to GoodRx for Weight Loss can also access FDA-approved, brand-name GLP-1 medications.

  • Save with a copay savings card. If you have commercial insurance, you could pay as little as $25 for Wegovy or $25 for Zepbound monthly supplies with a manufacturer copay savings card.

  • Save with an online pharmacy service. NovoCare Pharmacy and LillyDirect can ship GLP-1 medications directly to your home at lower, self-pay prices.

  • Save with a generic. Saxenda is the only GLP-1 for weight loss that’s available as a lower-cost generic. With a free GoodRx coupon, you could pay as little as $372.45 for 1 carton of generic liraglutide at certain pharmacies.

Frequently asked questions

Most GLP-1s are injected under the skin using a prefilled pen or syringe and vial. Some pens only need to be pressed against the skin to inject, while others have a button to push at the top. Common injection sites include the stomach, thigh, or upper arm.

Your healthcare team can show you how to inject your specific GLP-1.

Not exactly. Mounjaro (tirzepatide) works by acting like GLP-1, similar to other GLP-1 receptor agonists. But it also acts like a second hormone called GIP, which puts it into its own medication class along with Zepbound. Mounjaro is sometimes called a dual GIP / GLP-1 receptor agonist.

GLP-1 stands for glucagon-like peptide-1, an incretin hormone that’s naturally made in the intestines after you eat. It helps regulate blood glucose (sugar) levels by increasing insulin release, reducing sugar production in the liver, and slowing stomach emptying. It also binds to areas in the brain that regulate appetite and feelings of fullness.

It depends on the medication. Some GLP-1 medications are injected once daily, while others are injected once weekly. There are also GLP-1 pills that are taken by mouth every day.

The bottom line

Glucagon-like peptide-1 (GLP-1) injections — such as Wegovy and Wegovy HD (semaglutide), Zepbound (tirzepatide), and Saxenda (liraglutide) — work well for weight loss. Many people see significant results, but responses and side effects vary. These medications also work best when combined with lifestyle changes and long-term use.

If you’re thinking about starting GLP-1 injections, a healthcare professional can help you weigh the potential benefits, risks, and costs. Understanding what to expect up front can help you decide whether a GLP-1 injection is right for you.

why trust our exports reliability shield

Why trust our experts?

Alyssa Billingsley, PharmD, is the director of pharmacy content for GoodRx. She has over a decade of experience as a pharmacist and has worked in clinical, academic, and administrative roles.
Christina Aungst, PharmD, MWC is a senior pharmacy editor for GoodRx. She began writing for GoodRx Health in 2019.

References

Hathaway, J. T., et al. (2024). Risk of nonarteritic anterior ischemic optic neuropathy in patients prescribed semaglutide. JAMA Ophthalmology.

Jastreboff, A. M., et al. (2022). Tirzepatide once weekly for the treatment of obesity. The New England Journal of Medicine

GoodRx Health has strict sourcing policies and relies on primary sources such as medical organizations, governmental agencies, academic institutions, and peer-reviewed scientific journals. Learn more about how we ensure our content is accurate, thorough, and unbiased by reading our editorial guidelines.

Was this page helpful?

Latest articles